293 related articles for article (PubMed ID: 37209195)
21. Combined treatment of primary vitreoretinal lymphomas significantly prolongs the time to first relapse.
Klimova A; Heissigerova J; Rihova E; Brichova M; Pytlik R; Spicka I; Mrazova K; Karolova J; Svozilkova P
Br J Ophthalmol; 2018 Nov; 102(11):1579-1585. PubMed ID: 29378728
[TBL] [Abstract][Full Text] [Related]
22. Vitreoretinal lymphoma: changing trends in diagnosis and local treatment modalities at a single institution.
Turaka K; Bryan JS; De Souza S; Gordon AJ; Kwong HM; Ziemianski MC; Reddy R; Sell CH
Clin Lymphoma Myeloma Leuk; 2012 Dec; 12(6):412-7. PubMed ID: 22995952
[TBL] [Abstract][Full Text] [Related]
23. Vitreoretinal presentation of secondary large B-cell lymphoma in patients with systemic lymphoma.
Salomão DR; Pulido JS; Johnston PB; Canal-Fontcuberta I; Feldman AL
JAMA Ophthalmol; 2013 Sep; 131(9):1151-8. PubMed ID: 23744124
[TBL] [Abstract][Full Text] [Related]
24. Association between ocular findings and preventive therapy with onset of central nervous system involvement in patients with primary vitreoretinal lymphoma.
Hashida N; Nakai K; Saitoh N; Nishida K
Graefes Arch Clin Exp Ophthalmol; 2014 Apr; 252(4):687-93. PubMed ID: 24549401
[TBL] [Abstract][Full Text] [Related]
25. [Research progress in the diagnosis of primary vitreoretinal lymphoma].
Tuo YR; Zhang MF
Zhonghua Yan Ke Za Zhi; 2023 Nov; 59(11):954-959. PubMed ID: 37936364
[TBL] [Abstract][Full Text] [Related]
26. Refractory Primary Vitreoretinal Lymphoma Involving the Spinal Cord with a Temporary Complete Response to Tirabrutinib.
Iizuka-Honma H; Takizawa H; Mitsumori T; Okura H; Ishii H; Noguchi M
Intern Med; 2023 Feb; 62(3):459-463. PubMed ID: 35793963
[TBL] [Abstract][Full Text] [Related]
27. Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium.
Chan CC; Rubenstein JL; Coupland SE; Davis JL; Harbour JW; Johnston PB; Cassoux N; Touitou V; Smith JR; Batchelor TT; Pulido JS
Oncologist; 2011; 16(11):1589-99. PubMed ID: 22045784
[TBL] [Abstract][Full Text] [Related]
28. Survival and Recurrence in Vitreoretinal Lymphoma Simulating Uveitis at Presentation: The Possible Role of Combined Chemotherapy.
Gozzi F; Aldigeri R; Mastrofilippo V; De Simone L; Bolletta E; Marzano J; Iannetta D; Coassin M; Ilariucci F; Ferrari A; Luminari S; Merli F; Croci S; Zerbini A; Farnetti E; Nicoli D; Valli R; Tamagnini I; Cavazza A; Salvarani C; Fontana L; Cimino L
Ocul Immunol Inflamm; 2022; 30(7-8):1833-1841. PubMed ID: 34379571
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of first-line combination therapy versus monotherapy for vitreoretinal lymphoma: a systematic review and meta-analysis.
Gao J; Peng X; Wang L
BMC Ophthalmol; 2023 Nov; 23(1):477. PubMed ID: 37993841
[TBL] [Abstract][Full Text] [Related]
30. Primary vitreoretinal lymphoma: short review of the literature, results of a European survey and French guidelines of the LOC network for diagnosis, treatment and follow-up.
Malaise D; Houillier C; Touitou V; Choquet S; Maloum K; Le Garff-Tavernier M; Davi F; Vincent-Salomon A; Feuvret L; Hoang-Xuan K; Cassoux N; Soussain C;
Curr Opin Oncol; 2021 Sep; 33(5):420-431. PubMed ID: 34292201
[TBL] [Abstract][Full Text] [Related]
31. Relationship between vitreoretinal lymphoma and the site of lymphoma development in the central nervous system.
Maruyama K; Iwahashi C; Hashida N; Ohguro N; Nishida K
Jpn J Ophthalmol; 2022 Mar; 66(2):142-150. PubMed ID: 34860298
[TBL] [Abstract][Full Text] [Related]
32. Vitreoretinal lymphoma: Central nervous system lymphoma risk with unilateral or bilateral ocular tumour. A multicentre collaboration.
Dalvin LA; Pulido JS; Shields CL; Marchese A; Miserocchi E; Frenkel S; Pe'er J
Eye (Lond); 2023 Jan; 37(1):54-61. PubMed ID: 34999721
[TBL] [Abstract][Full Text] [Related]
33. Optical coherence tomography features in vitreoretinal lymphoma compared with non-infectious uveitis.
El Zein L; Smith WM; White LJ; Hodge DO; Olsen TW; Pulido JS; Dalvin LA
BMC Ophthalmol; 2024 Jun; 24(1):255. PubMed ID: 38872120
[TBL] [Abstract][Full Text] [Related]
34. Spectral-domain optical coherence tomography biomarkers in vitreoretinal lymphoma.
Guan W; Xiao Y; Zhao H; Hu F; Chen C; Peng X
Clin Exp Ophthalmol; 2023 Mar; 51(2):144-153. PubMed ID: 36567492
[TBL] [Abstract][Full Text] [Related]
35. Vitreous proteomics, a gateway to improved understanding and stratification of diverse uveitis aetiologies.
Schrijver B; Kolijn PM; Ten Berge JCEM; Nagtzaam NMA; van Rijswijk ALCT; Swagemakers SMA; van der Spek PJ; Missotten TOAR; van Velthoven MEJ; de Hoog J; van Hagen PM; Langerak AW; Dik WA
Acta Ophthalmol; 2022 Jun; 100(4):403-413. PubMed ID: 34318583
[TBL] [Abstract][Full Text] [Related]
36. Comparative Molecular Analysis of Primary Central Nervous System Lymphomas and Matched Vitreoretinal Lymphomas by Vitreous Liquid Biopsy.
Balikov DA; Hu K; Liu CJ; Betz BL; Chinnaiyan AM; Devisetty LV; Venneti S; Tomlins SA; Cani AK; Rao RC
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576156
[TBL] [Abstract][Full Text] [Related]
37. [Diagnostics and treatment of primary vitreoretinal lymphoma].
Stübiger N; Kakkassery V; Gundlach E; Winterhalter S; Pleyer U
Ophthalmologe; 2015 Mar; 112(3):223-30. PubMed ID: 25698590
[TBL] [Abstract][Full Text] [Related]
38. [Molecular diagnostics for vitreoretinal lymphoma].
Bonzheim I; Salmerón-Villalobos J; Süsskind D; Szurman P; Gekeler F; Spitzer MS; Salaverria I; Campo E; Coupland SE; Quintanilla-Martinez L; Fend F
Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):150-154. PubMed ID: 37947807
[TBL] [Abstract][Full Text] [Related]
39. Intraocular lymphoma: a clinical perspective.
Davis JL
Eye (Lond); 2013 Feb; 27(2):153-62. PubMed ID: 23196650
[TBL] [Abstract][Full Text] [Related]
40. DIFFERENTIAL DIAGNOSIS FOR VITREORETINAL LYMPHOMA WITH VITREORETINAL FINDINGS, IMMUNOGLOBULIN CLONALITY TESTS, AND INTERLEUKIN LEVELS.
Lee J; Kim SW; Kim H; Lee CS; Kim M; Lee SC
Retina; 2019 Jun; 39(6):1165-1176. PubMed ID: 29474309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]